Endevica Bio Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$10M
- Investors
-
3
Endevica Bio General Information
Description
Developer of therapeutic drugs intended to treat cachexia due to cancer and other chronic conditions. The company's drugs are melanocortin-based peptide drugs for treating cardiovascular problems which are free from any adverse cardiovascular side effects, enabling healthcare practitioners to use these drugs for the treatment of cancer and other chronic diseases.
Contact Information
Website
www.endevicabio.comCorporate Office
- 1935 Techny Road
- Suite 14
- Northbrook, IL 60062
- United States
Corporate Office
- 1935 Techny Road
- Suite 14
- Northbrook, IL 60062
- United States
Endevica Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 19-Jan-2023 | $10M | Completed | Generating Revenue | ||
| 2. Grant | 01-Jun-2017 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series A) | 01-Jun-2016 | $1.7M | $1.7M | Completed | Generating Revenue |
Endevica Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Endevica Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Endevica Bio Patents
Endevica Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10829519-B2 | Angiotensin (1-7) analogs and methods relating thereto | Active | 18-Sep-2015 | ||
| CA-2998862-A1 | Angiotensin (1-7) analogs and methods relating thereto | Inactive | 18-Sep-2015 | ||
| EP-3350200-A2 | Angiotensin (1-7) analogs and methods relating thereto | Inactive | 18-Sep-2015 | ||
| US-20190241616-A1 | Angiotensin (1-7) analogs and methods relating thereto | Active | 18-Sep-2015 | ||
| EP-3350200-A4 | Angiotensin (1-7) analogs and methods relating thereto | Inactive | 18-Sep-2015 | C07K7/06 |
Endevica Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Endevica Bio Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Cancer Institute | Government | |||
| Centennial Investors | Angel Group | Minority | ||
| Missouri Technology Corporation | Venture Capital | Minority |
Endevica Bio FAQs
-
When was Endevica Bio founded?
Endevica Bio was founded in 2009.
-
Where is Endevica Bio headquartered?
Endevica Bio is headquartered in Northbrook, IL.
-
What is the size of Endevica Bio?
Endevica Bio has 10 total employees.
-
What industry is Endevica Bio in?
Endevica Bio’s primary industry is Drug Discovery.
-
Is Endevica Bio a private or public company?
Endevica Bio is a Private company.
-
What is the current valuation of Endevica Bio?
The current valuation of Endevica Bio is .
-
What is Endevica Bio’s current revenue?
The current revenue for Endevica Bio is .
-
How much funding has Endevica Bio raised over time?
Endevica Bio has raised $11.7M.
-
Who are Endevica Bio’s investors?
National Cancer Institute, Centennial Investors, and Missouri Technology Corporation have invested in Endevica Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
